These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6539514)

  • 1. Fibrinolytic activity in healthy volunteers before and after 5 to 20 minutes of venous occlusion.
    Bauer J; Bachmann F
    Thromb Res; 1984 Apr; 34(2):159-74. PubMed ID: 6539514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of vascular plasminogen activator (v-PA) after venous stasis: electrophoretic-zymographic analysis of free and complexed v-PA.
    Stalder M; Hauert J; Kruithof EK; Bachmann F
    Br J Haematol; 1985 Sep; 61(1):169-76. PubMed ID: 4052324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic plasma fibrinolysis: involvement of urokinase-related activity in the factor XII-independent plasminogen proactivator pathway.
    Kluft C; Wijngaards G; Jie AF
    J Lab Clin Med; 1984 Mar; 103(3):408-19. PubMed ID: 6199446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
    Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
    Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activators in dextran sulfate-activated euglobulin fractions: a molecular analysis of factor XII- and prekallikrein-dependent fibrinolysis.
    Hauert J; Nicoloso G; Schleuning WD; Bachmann F; Schapira M
    Blood; 1989 Mar; 73(4):994-9. PubMed ID: 2465792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolytic properties of activated FXII.
    Braat EA; Dooijewaard G; Rijken DC
    Eur J Biochem; 1999 Aug; 263(3):904-11. PubMed ID: 10469157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A delaying influence of cryoglobulins in the assessment of euglobulin fibrinolytic activity.
    Gram J; Jespersen J; Astrup T
    Thromb Res; 1986 Mar; 41(6):781-9. PubMed ID: 2422781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rapid separation and assay of previously unreported plasminogen activators in human euglobulin fractions. The effect of venous occlusion.
    Millar WT; Smith JF
    Thromb Res; 1984 Aug; 35(3):291-9. PubMed ID: 6540485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolytic studies in 13 unrelated families with factor XII deficiency.
    Rodeghiero F; Castaman G; Ruggeri M; Cazzavillan M; Ferracin G; Dini E
    Haematologica; 1991; 76(1):28-32. PubMed ID: 2055558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility of fibrinolytic response to venous occlusion in healthy subjects.
    Stegnar M; Mavri A
    Thromb Haemost; 1995 Mar; 73(3):453-7. PubMed ID: 7667828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator.
    Jespersen J; Kluft C
    Thromb Haemost; 1985 Aug; 54(2):454-9. PubMed ID: 2417350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diurnal variation of the fibrinolytic system.
    Grimaudo V; Hauert J; Bachmann F; Kruithof EK
    Thromb Haemost; 1988 Jun; 59(3):495-9. PubMed ID: 3142085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein.
    Binnema DJ; Dooijewaard G; Turion PN
    Thromb Haemost; 1991 Feb; 65(2):144-8. PubMed ID: 1905069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of plasminogen activator in human plasma using the method of fibrin/celite column chromatography--with special reference to the determination of fibrin adsorbable tissue-plasminogen activator by ELISA].
    Ieko M
    Hokkaido Igaku Zasshi; 1985 Nov; 60(6):834-47. PubMed ID: 4085966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibrinolytic activity and tissue plasminogen activator level in healthy individuals prior to and after a ten-minute venous stasis].
    Kubicka A; Libura M; Sacha T; Swadźba J; Undas A; Wandzilak M
    Pol Tyg Lek; 1993 Feb 1-8; 48(5-6):116-9. PubMed ID: 8361905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay characteristics and fibrin affinity of plasminogen activators of the intrinsic fibrinolytic system.
    Kok P; Nilsson T
    Thromb Res; 1986 Jan; 41(2):197-209. PubMed ID: 2421431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin and venous occlusion: effects on blood fibrinolytic activity and tissue-type plasminogen activator levels.
    Hammouda MW; Moroz LA
    Thromb Res; 1986 Apr; 42(1):73-82. PubMed ID: 3085277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology.
    Gris JC; Neveu S; Mares P; Biron C; Hedon B; Schved JF
    J Lab Clin Med; 1993 Nov; 122(5):606-15. PubMed ID: 8228580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
    Grimaudo V; Bachmann F; Hauert J; Christe MA; Kruithof EK
    Thromb Haemost; 1992 Apr; 67(4):397-401. PubMed ID: 1631786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.